Literature DB >> 12427162

Treatment of primary focal segmental glomerulosclerosis.

Stephen M Korbet1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427162     DOI: 10.1046/j.1523-1755.2002.00674.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  20 in total

Review 1.  Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.

Authors:  Hernán Trimarchi
Journal:  World J Nephrol       Date:  2013-11-06

2.  Collapsing focal segmental glomerulosclerosis: Current concepts.

Authors:  Muhammed Mubarak
Journal:  World J Nephrol       Date:  2012-04-06

3.  Rethinking First-Line Immunosuppression for Idiopathic FSGS.

Authors:  Jordana B Cohen; Jonathan J Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-16       Impact factor: 8.237

4.  Nephrotic syndrome due to focal segmental glomerulosclerosis occurring in early pregnancy.

Authors:  A Smyth; C A Wall
Journal:  Obstet Med       Date:  2011-05-17

5.  Collapsing FSGS: a clinicopathologic study of 10 cases from Pakistan.

Authors:  Muhammed Mubarak; Javed I Kazi
Journal:  Clin Exp Nephrol       Date:  2010-03-12       Impact factor: 2.801

6.  Focal and segmental glomerulosclerosis in children: a longitudinal assessment.

Authors:  Olivia Boyer; Janelle K Moulder; Michael J G Somers
Journal:  Pediatr Nephrol       Date:  2007-04-17       Impact factor: 3.714

7.  Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.

Authors:  Jun Oto; Kenichi Suga; Sato Matsuura; Shuji Kondo; Yoshiaki Ohnishi; Daisuke Inui; Hideaki Imanaka; Shoji Kagami; Masaji Nishimura
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

8.  Idiopathic collapsing glomerulopathy in children.

Authors:  Ashima Gulati; Alok Sharma; Pankaj Hari; Amit K Dinda; Arvind Bagga
Journal:  Clin Exp Nephrol       Date:  2008-04-08       Impact factor: 2.801

9.  Reversibility of pamidronate-associated glomerulosclerosis.

Authors:  Meera Shreedhara; Andrew Z Fenves; Diana Benavides; Marvin J Stone
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

10.  Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.

Authors:  Beom Seok Kim; Hyeong Cheon Park; Shin Wook Kang; Kyu Hun Choi; Sung Kyu Ha; Dae Suk Han; Ho Yung Lee
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.